LISTSERV 16.0 - PARKINSN Archives

Subscriber's Corner

Email Lists

PARKINSN Archives

PARKINSN@LISTSERV.UTORONTO.CA

View:

Message:

[

First

Last

]

By Topic:

[

First

Last

]

By Author:

[

First

Last

]

Font:

Monospaced Font

		LISTSERV Archives
		PARKINSN Home
		PARKINSN August 1997, Week 5

Subject:

CSRINDX Part 2

From:

"J. R. Bruman" <[log in to unmask]>

Reply-To:

[log in to unmask]

Date:

Mon, 1 Sep 1997 13:43:02 -0400

Content-Type:

text/plain

Parts/Attachments:

text/plain (300 lines)

Hitler's PD observed May 97 Mov Disord Hydrocarbon, caused by Mar 97 Ann Neur Incidence (survey) Jun 97 Neur " Inderal, for dyskinesiaJul 96 Neur Iron, possible cause Jul 96 Lancet Iron, elevated Jan 95 Ann Neur " Jet fuel, hazard of Sep 97 BMJ Juvenile PD Sep 96 Neur Kava Jun Keats, John Jan 95 Arch Neur Lamotrigine Jun 97 Neur Lazabemide Aug 96 Ann Neur Leukemia drugs Jul 95 Ann Neur Levodopa strategy Oct 95 Ann Neur " " Levodopa effects Jan 96 Neur " " " " Levodopa ethylester Apr 96 Ann Neur Levodopa dual-release May 97 J Clin Neuropharm Lewy body disease Jun " " Liquid Sinemet Feb 97 Neur Locus coeruleus Jun 95 Brain Machado-Joseph Nov 95 Ann Neur Macrophage Oct 96 Science News Magnetic stimulation May 96 Brain " " MAO inhibition, effect May 97 J Neurosci MAO-B Jun 96 Neur " Markers, neurochemical Oct 96 Neur " " Melatonin Jun 96 BMJ " Memory, Hippocampus Oct 96 Science News Memory and PD Oct 96 Science " " Menstrual effects Jul 95 Neur " Metaclopramide (Reglan)Jan 96 JAMA Metals, exposure to Apr 97 Neur Methylsalsolinol Aug 96 Ann Neur Metronome Jun 96 Lancet Migraine, DA and May 97 J Clin Neuropharm Mimics of PD Oct 95 Arch Neur " " Mitochondria Sep 95 Science News " " Mortality Apr " Motor Fluctuations Aug Movement, head and eye Jul 96 Ann Neur " , coordinated " , " " , " " , diagnostic " , guidance MPTP Dec 94 Ann Neur " " Multiple System AtrophyMar 95 Ann Neur " " Muscle, sound from Apr 97 Lancet Nerve Growth Factor Apr 96 J Neurosurg " " " " Neuroleptics (risk) Mar Neuropeptides Sep 96 Brain Neurosciences Inst. Dec 95 Science Neurotrophic factors Oct 96 Ann Neur " " Neurotrophic (GDNF) Apr 96 WSJ " NMDA antagonist Nov 96 J Neurosci " Nurr-1 May 97 Science " Nutrients and PD Oct 96 Neur Olfaction and PD Jul Ondansetron (Zofran) Oct 95 Neur " " On-off effect Dec " Onset, early vs late Aug 97 Mov Disord Oxidative stress May 95 Neur " " Pallidopyramidal Feb 96 Ann Neur Pallidotomy, boom in Mar 95 WSJ " " " " " " " " " " " " " " " " " " " Paroxetine (Paxil) Jan 95 Neur Pathways, neural May 95 Neur " Perception, visual May 96 Brain Pergolide (Permax) May 95 Neur " " " Personality and PD Mar 97 Lancet PET diagnosis Dec 94 Ann Neur " " " " " " " " " " " " scans, Porphyria and PD drugs Jul Pramipexole Apr 96 PDF Newsletter " " Prevalence Mar Prions May 96 Science News Progenitor cells Nov 95 Eng. & Sci Progression (case hist)Feb 96 NEJM " " " Progressive Supranuc. Jun " " " " Propranolol Jul 96 Neur Propath program Oct 96 Arch Neur Proton Magnetic Res. Apr Prozac (fluoxetine) Nov 95 Neur Psychogenic PD Sep 95 Arch Neur Quality of life Aug Raclopride, in PET Feb 97 Mov Disord Rapid-onset May 97 Neur Rating scale, clinical Sep 97 J Clin Neuropharm " Reaction time Dec " Reflex blink, and PD Dec 96 J Neurosci Regeneration, brain Apr 96 Lancet " " " Registry (surveys) Feb 96 Neur " " " Research priorities Nov 95 JAMA Response time, levodopaJun 96 Neur " Restless leg syndrome Feb 96 JAMA " " " Rigidity Feb 97 Mov Disord Risperidone Feb 97 Mov Disord " Salsolinol Aug 96 Ann Neur Selegiline , PET scan Dec 94 Ann Neur " " " " " " " " " " " " " " " " " " " " " ", Serotonin syndrome Mar 97 Neur " Shy-Drager Mar 95 Ann Neur Sinemet, dissolved Sep 97 Mov Disord Sinemet CR Jul " Sjogren's syndrome Feb 97 Mov Disord Sleep, violence in Jun 97 Lancet " , benefit Smell, loss of Jul Smoking and PD Sep 95 Neur " " " " " SPECT, diagnosis by Apr 96 Neur " " " Speech therapy Feb 97 Neur Stem cells, cultured Aug 97 Science News " Stereotactic Aug 95 J Neurosurg " Stimulation, chronic Jun 96 Neur " Strategy, summary May 97 J Clin Neuropharm Strength, arm Mar 96 Ann Neur " Striatonigral degener- Nov 96 Neur Stroke, help from Feb 97 Mov Disord " , Surgery, summary Mar Swallowing Mar 97 Neur " Sweats, control of Mar 95 Ann Neur Symmetrel (Amantadine) Jul 96 Neur Tachyphemia Aug 97 Mov Disord Tacrine, PD symptoms Oct Tactile acuity Aug 97 Neur Tardive dyskinesia Feb 97 Mov Disord " Thalamotomy Jun " " Thalamus, and tremor Mar 96 Neur " Therapy, tutorial Jul 96 Western J Med " Time, judgement of Mar 96 Science News " Tolcapone Feb 97 Neur Toxins, Environmental Dec 94 Ann Neur " " " Tracking, visual Jun 95 Brain Transcranial mag. stim May 97 J Neurosci " Tremor, resting PD Jun 96 Neur ", cerebellar ", Tourette Syndrome Aug 97 Mov Disord Ubiquitin Feb 96 Brain Urinary dysfunction Jul " Valproate Oct 96 Neur Visual perception May 96 Brain Vision abnormality Oct 95 Neur Visuospatial attention Jun 95 Brain Weight loss Feb 97 Neur Wine and dementia May 97 BMJ Young onset Sep 96 Neur " " Zolpidem Jun 97 Lancet "
--
J. R. Bruman (818) 789-3694
3527 Cody Road
Sherman Oaks, CA 91403-5013 1997;12:239-240
1996;40:922-925
1997;48:1277-1281
, Argentina May 97 Mov Disord 1997;12:197-205
1996;46:1548-1551
8 Jun 1996;1614
1994;36;876-881
Oct 95 Neur 1995;45:1138-1143
2 Aug 97:275
1996;47:160-166
95 J Neur N'surg Psych 1995;58:639-640
1994;51:1182-1183
1997;48:1282-1286
1996;40:99-107
1995;37:810-814
1995;38:389-395
Dec 95 J Neur N'surg Psych 1995;59:555
Feb 97 Neur 1996;47:Supp 3
1995;45:1757-1760
Jun 96 Neur 1996;46:1430-1436
Aug 96 J Neur N'surg Psych 1996;61:634-637
Feb 97 Mov Disord 1997;12:103-106
Sep 97 Ann Neur 1997;42:245-248
1996;39:400-404
1997;20:130-139
96 J Neur N'surg Psych 1996;60:531-538
Sep 96 Neur 1996;47:462-466
Mar 97 Neur 1997;48:376-380
1996;47:1493-1495
1995;118:131-143
1995;38:684-687
21 Sep 96:180
1996;119:71-77
Sep 96 Brain 1996;119:815-822
Oct 96 Ann Neur 1996;40:344-355
1997;17:2267-2272
1996;46:1262-1269
Aug 96 Ann Neur 1996;40:99-107
1996;47:718-726
" May 97 Mov Disord 1997;12:167-174
" May 97 Ann Neur 1997;41;530-539
18 May 96:1242-43
, antioxidant Apr 97 J Neurosci 1997;17:1683-1690
7 Sep 1996:150
6 Sep 96:1263-64
Oct 96 Science 6 Sep 96:1399-02
Jun 97 J Neur N'surg Psych 1997;62:410-413
1995;45:1028
Nov 95 Mov Disord 1993;8:240-241
1995;274:1780-82
1997;48:650-658
1996;40:119-122
11 May 1996:1337
1997;20:36-41
1995;58:294-298
Oct 95 Brain 1995;118:951-958
Apr 96 BMJ 16 Mar 1996:724
5 Aug 1995;84
Feb 96 Neur 1995;45:2097-2099
Feb 97 Mov Disord 1997;12:3-16
95 J Neur N'surg Psych 1995;58:293-299
Apr 97 Arch Neur 1997;54:260-264
96 J Neur N'surg Psych 1996;61:634-637
1996;39:749-760
Apr 97 Brain 1997;120:91-102
Jun 97 Brain 1997;120:593-604
Aug 97 Brain 1997;120:963-976
May 97 Arch Neur 1997;54:450-454
Aug 97 Brain 1997;120:977-990
1994;36:765-770
Jan 97 J Neurosci 1996;16:7776-7782
Feb 97 Neur 1996;47:Supp 3
1995;37:204-210
Sep 95 J Neur N'surg Psych 1995;59:144-151
Sep 97 J Clin Neuropharm 1997;20:239-244
22 Feb 97;533-535
1996;84:685-689
Nov 96 J Neurosci 1996;16:5437-5442
Nov 96 J Neurosci 1996;16:6433-6442
Jul 97 J Neurosurg 1997;86:511-518
and diabetes Nov 96 Lancet 19 Oct 96:1044-45
96 J Neur N'surg Psych 1996;60:213-216
1996;119:823-830
27 Oct 1995:572
1996;40:346
problems Jul 97 Nat Med 1997;3:497
(BDNF) May 97 J Neurosci 1997;17:2295=2313
21 Mar 1996:
Jan 97 N Neurosci 16:8132-8139
1996;16:4231-39
May 97 J Neurosci 1997;17:2921-2927
11 Apr 97:248-50
, editorial May 97 Science 11 Apr 97:202
1996;47:644-650
97 J Neur N'surg Psych 1997;62:436-446
1995;45:1305-1308
Feb 97 Neur 1996;47:1608-1609
, for tremor Apr 97 J Neur N'Surg Psych 1997;62:282-284
95 J Neur N'surg Psych 1995;59:555
Aug 96 J Neur N'surg Psych 1996;61:634-637
1997;12:277-284
1995;45S3:55
Aug 95 J Neur N'surg Psych 1995;59:90-91
Apr 96 Ann Neur 1996;39:378-381
1995;38:954-956
22 Feb 95:1
, benefits Jun 96 Neur 1995;45:753-761
, " Jul 96 Lancet 25 May 96;1490
, " Jul 96 Ann Neur 1996;39:826
, " Apr 97 J Neur N'surg Psych 1997;62:125-132
, " Apr 97 Lancet 15 Mar 1997:777
, " Jun 97 Neur 1997;48:1273-1277
, " Jul 97 Ann Neur 1997;41:834
, cognition Sep 97 Arch Neur 1997;54:947-950
, gamma knife Jun 96 Ann Neur 1996;39:535-538
, history Oct 96 Ann Neur 1996;40:341-343
, low-cost Jul 97 Brain 1997;120:729-737
, PET scan Jul 95 Ann Neur 1995;37:776-783
, PET scan Jun 96 Ann Neur 1996;39:450-459
, success Oct 96 Ann Neur 1996;40:355-366
, technique Jul 96 J Neurosurg 1996;84:194-202
, " Jan 97 J Neurosurg 1996;85:1005-1012
, " Aug 97 J Neurosurg 1997:87:52-59
and DBS Jul 97 Nat Med 1997;3:671-674
" " Jul 97 Nat Med 1997;3:602-603
1994;44:2406
1995;45S3:S28-S34
Nov 96 Neur 1996;1032-1036
1996;119:79-87
1995;45S3:S5
May 95 Neur 1995;45S3:S13-S21
May 95 Neur 1995;45S3:S22-S27
Aug 97 Mov Disord 1997;12:402-407
15 Feb 97:478
1994;36:759-764
Dec 94 Ann Neur 1994;2:176-182
Jan 96 J Neur N'surg Psych 1995;59:597-600
Feb 96 Neur 1995;45:1995-2004
Jun 96 Ann Neur 1996;39:450-459
Jun 96 Neur 1996;46:1430-1436
Jun 96 Neur 1996;46:1200-1205
Jun 96 Ann Neur 1996;39:650-658
Jul 96 Brain 1996;119:585-591
Sep 96 Neur 1996;47:462-466
Mar 97 Ann Neur 1996;40:873-884
Mar 97 Ann Neur 1997;41:58-64
questioned May 97 Science 11 Apr 97:196-198
97 J Neur N'surg Psych 1997;62:562
Spr 1996:1
Aug 97 JAMA 9 Jul 87:125-130
Aug 97 Neur 1997;49:162-168
97 J Neur N'surg Psych 1997;62:10-15
13 Apr 1996;228
Sept 95:26
1996;334:116-118
Apr 96 JAMA 6 Mar 1996:716
Nov 96 JAMA 9 Oct 1196;1171
, in putamen Mar 97 Brain 1996;119:2097-103
96 J Neur N'surg Psych 1996;60:589
Aug 96 J Neur N'surg Psych 1996;61:615-620
Sep 96 Neur 1996;47:1-9
Sep 96 Neur 1996;47:148-154
Apr 97 Brain 1997;120:65-74
1996;46:1548-1551
1996;53:881-884
97 J Neur N'Surg Psych 1997;62:239-242
1995;45:1855-1858
1995;52:802-810
96 J Neur N'surg Psych 1996;61:71-74
1997;12:33-38
1997;49:1066-1069
1997;20:183-184
" Sep 97 J Clin Neuropharm 1997;20:322-327
95 J Neur N'surg Psych 1995;59:499-506
Jan 97 Brain 1996;119:1689-1704
1996;16:7308-7330
16 Mar 1996:751
Oct 96 Science News 21 Sep 1996:180
Apr 97 Science 28 Feb 97;1318-19
, spinal cord Oct 96 Lancet 21 Sep 1996:814
1995;45:1991-1995
Feb 96 NEJM 1996;334:71-76
Feb 96 Neur 1995;45:2143-2146
Feb 96 Arch Neur 1996;53:66-71
25 Oct 95:1257-8
1996;46:1055-1058
Jun 96 Neur 1996;46:1059-1062
17 Jan 1996:
Feb 97 Neur 1996;47:1435-1441
May 97 J Clin Neuropharm 1997;20:148-151
Aug 97 Mov Disord 1997;12:402-407
1997;12:24-32
1997;12:119-121
Sep 97 Mov Disord 1997;12:610-612
1996;40:119-122
1994;36:759-764
, and AD May 97 NEJM 14 Apr 97:1216-22
, benefits Feb 95 Ann Neur 1995;37:95-98
, " May 97 Mov Disord 1997;12:175-182
' " Jul 97 Ann Neur 1997;41:833-834
, DATATOP Apr 95 Arch Neur 1995;52:237-245
, " Nov 95 Arch Neur 1995;52:564-570
, " Mar 96 Ann Neur 1996;39:37-45
, " Mar 96 Ann Neur 1996;39:29-36
, dosage Aug 97 Mov Disord 1997;12:293-296
, amphetamine Oct 95 Lancet 1995;346:64
, protection by Jan 96 Ann Neur 1995;38:771-777
" Aug 97 J Neurochem 1997;68:33-39
" Aug 97 J Neurochem 1997;68:434-436
, risks of Jan 96 BMJ 16 Dec 95:1602-7
, " Mar 97 Ann Neur 1996;40:841-845
, " Apr 97 Neur 1997;48:662-667
, " Sep 97 J Clin Neuropharm 1997;20:276-278
, in favor of Apr 96 PDF Newsletter Spr 1996:2
, pro and con Apr 96 BMJ 16 Mar 96:702-705
, " " " Sep 96 Ann Neur 1996;40:266-269
, " " " Mar 97 Ann Neur 1997;41:282-283
special review Feb 97 Neur 1996;47:Supp 3
1997;48:1070-1077
antagonist Sep 97 J Clin Neuropharm 1997;20:300-310
1995;37:204-210
1997;12:608-610
95 J Neur N'surg Psych 1995;58:ad
Dec 95 Lancet 11 Nov 1995;1290
1997;12:121-123
19 Apr 97;1150
Sep 97 Mov Disord 1997;12:506-508
97 J Neur N'surg Psych 1997;62:436-446
1995;45:1041
Oct 95 Neur 1995;58:294-298
Apr 96 Time 11 Mar 1996:60
Apr 96 Lancet 24 Feb 1996:527
Apr 96 Ann Neur 1996;39:378-381
Jun 96 Neur 1996;46:1275-1284
1996;46:278-285
Apr 96 Neur 1996;46:231-237
Apr 97 Brain 1997;120:103-110
Apr 97 J Neur N'surg Psych 1997;62:133-140
1996;47:1496-1504
19 Jul 97:36
, review of May 97 Science 4 Apr 1997:66-71
1995;83:197-205
Apr 96 Science News 30 Mar 1996:204
1996;46:1150-1153
Oct 96 Arch Neur 1996;53:898-903
1997;20:95-115
1996;39:79-88
Jun 97 Brain 1997;120:401-408
1996;47:1032-1036
1997;12:124-126
adverse effect Apr 97 J Neur N'surg Psych 1997;62:288-289
97 J Neur N'surg Psych 1997;62:2-8
1997;48:373-375
Aug 97 Mov Disord 1977;12:322-327
1995;37:120-122
1996;46:1551-1556
1997;12:302-305
96 J Neur N'surg Psych 1996;61:324-325
1997;49:168-177
1997;12:119-121
" , and PVP Apr 97 Lancet 15 Mar 1997:777
96 J Neur N'surg Psych 1996;60:564-571
Jan 97 Brain 1996;1717-1727
Mar 97 Ann Neur 1997;41:108-111
1996;46:75-79
Jun 96 Neur 1996;46:1150-1153
1994;161:303-308
Jul 96 Postgrad Med 1996;99:52-68
17 Feb 1996:101
May 96 Brain 1996;119:51-70
1997;48:81-87
1994;36:765-770
Apr 95 Neur 1995;45:435-439
Feb 96 Neur 1995'45:2112
Jul 97 Neur 1997;48:1583-1588
1995;118:485-493
1997;17:3178-3184
Aug 97 Mov Disord 1997;12:315-321
1996;46:1359-1370
Apr 97 J Neur N'surg Psych 1997;62:282-284
surgery for May 97 J Neurosurg 1997;86:642-647
1997:12:402-407
1995;118:1447-49
97 J Neur N'surg Psych 1997;62:507-511
" Sep 97 Mov Disord 1997;12:509-513
1996;47:626-635
1996;119:79-87
1995;45:1144-1148
1995;118:153-166
1997;48:88-91
5 Apr 97:997
1996;47:225-230
Aug 97 Mov Disord 1997;12:277-284
26 Apr 97;1222-23
Aug 97 Lancet 5 Jul 97;74

Top of Message | Previous Page | Permalink

Search Archives

Advanced Options

Options

		Log In
		Get Password

		Search Archives

		Subscribe or Unsubscribe

Archives

ATOM RSS1 RSS2

LISTSERV.UTORONTO.CA